Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF

Medicine and Dentistry

• Base 10%
• Cells 30%
• Chondroitin Sulfate 100%
• Combination Therapy 10%
• Culture 10%
• Development 10%
• Flow Cytometry 10%
• Immunofluorescence Microscopy 10%
• Long Term Exposure 10%
• MAPK Signaling 10%
• MEK Inhibitor 30%
• Melanoma Cell 30%
• Melanoma Cell Line 10%
• Messenger RNA 20%
• Neoplasm 20%
• Nodular Melanoma 10%
• Phosphotransferase Inhibitor 10%
• Protein 20%
• Protein Tyrosine Kinase 10%
• Proteochondroitin Sulfate 10%
• Proteoglycan 10%

Biochemistry, Genetics and Molecular Biology

• Chondroitin Sulfate 100%
• Chondroitin Sulfate Proteoglycan 10%
• Development 10%
• Flow Cytometry 10%
• Fluorescence Activated Cell Sorting 20%
• Immunofluorescence 10%
• Kinase 10%
• MAPK Signaling 10%
• MEK Inhibitor 30%
• Messenger RNA 20%
• Microscopy 10%
• Mutation 10%
• Protein 20%
• Proteoglycan 10%
• Real-Time Polymerase Chain Reaction 20%
• Receptor Tyrosine Kinase 10%
• Sample 20%
• Supernatant 10%
• Western Blot 20%